Tirzepatide…
Do Weight Loss Differently
The US Food and Drug Administration (FDA) approved the use of Tirzepatide for treating type 2 diabetes mellitus (T2DM). Tirzepatide is a synthetic polypeptide and dual agonist for the glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptors. Therefore, the drug leads to significantly improved glycemic control and weight reduction in patients with T2DM, maximizing benefits similar to GLP-1 medications such as Semaglutide.